CDKN2A and melanoma: In familial human melanoma the predisposing alleles include loss‐of‐function mutations in CDKN2A, which encodes the p16 CDK inhibitor, and mis‐sense mutations in CDK4 which result in failure of p16 inhibition of the mutant kinase (Zuo et al., 1996).